Details for New Drug Application (NDA): 019817
✉ Email this page to a colleague
NDA 019817 describes IV PERSANTINE, which is a drug marketed by Boehringer Ingelheim and is included in one NDA. Additional details are available on the IV PERSANTINE profile page.
The generic ingredient in IV PERSANTINE is dipyridamole. There are eighteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.
The generic ingredient in IV PERSANTINE is dipyridamole. There are eighteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.
Summary for 019817
| Tradename: | IV PERSANTINE |
| Applicant: | Boehringer Ingelheim |
| Ingredient: | dipyridamole |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019817
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 13, 1990 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
